Alkermes plc

ALKS ·Healthcare, Drug Manufacturers - General, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $903.4M $745.7M $628.3M $618.8M $596.3M $390.0M $186.6M $178.3M
Cost of Revenue $154.7M $132.1M $139.0M $175.8M $170.5M $127.6M $52.2M $49.4M
Gross Profit $748.6M $613.6M $489.3M $443.0M $425.9M $262.4M $134.5M $128.8M
Gross Margin 82.9% 82.3% 77.9% 71.6% 71.4% 67.3% 72.0% 72.3%
Operating Expenses
Research & Development $412.9M $387.1M $344.4M $272.0M $140.0M $141.9M $97.2M $95.4M
SG&A Expense $421.6M $374.1M $311.6M $199.9M $125.8M $137.6M $82.8M $76.5M
Operating Income $-147.9M $-208.7M $-224.3M $-87.1M $34.5M $-88.3M $-45.6M $-43.0M
Operating Margin -16.4% -28.0% -35.7% -14.1% 5.8% -22.6% -24.4% -24.1%
Interest Expense $12.0M $14.9M $13.2M $13.4M $49.0M $28.1M $3.3M $6.0M
Pretax Income $-143.3M $-214.4M $-224.0M $-14.0M $13.3M $-114.4M $-46.5M $-44.7M
Income Tax Expense $14.7M $-5.9M $3.2M $16.0M $-7.4M $-714.0K $-951.0K $-5.1M
Net Income $-157.9M $-208.4M $-227.2M $-30.1M $20.6M $-113.7M $-45.5M $-39.6M
Net Margin -17.5% -28.0% -36.2% -4.9% 3.5% -29.1% -24.4% -22.2%
EPS (Basic) $-1.03 $-1.38 $-1.52 $-0.21 $0.15 $-0.99 $-0.48 $-0.42
EPS (Diluted) $-1.03 $-1.38 $-1.52 $-0.21 $0.14 $-0.99 $-0.48 $-0.42
Shares Outstanding (Basic) 154.0M 152.4M 149.2M 145.3M 135.3M 114.7M 95.6M 94.8M
Shares Outstanding (Diluted) 154.0M 152.4M 149.2M 145.3M 144.0M 114.7M 95.6M 94.8M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 2 Older →